Conventional heart failure therapy in cardiac ATTR amyloidosis

Adam Ioannou(The Royal Free Hospital), Marianna Fontana(Amyloidosis Foundation), Aviva Petrie(Eastman Dental Hospital), Mark C. Petrie(British Heart Foundation), Helen J. Lachmann(Royal Free London NHS Foundation Trust), Ashutosh Wechelakar(MACOM (United States)), Michele Emdin(Scuola Superiore Sant'Anna), Lucia Venneri(MACOM (United States)), John J.V. McMurray(University of Glasgow), Nick Freemantle(MRC Clinical Trials Unit at UCL), Philip N. Hawkins(The Royal Free Hospital), Ruta Virsinskaite(The Royal Free Hospital), Rishi Patel(Texas Tech University), Julian D. Gillmore(Alnylam Pharmaceuticals (United States)), Carol Whelan(The Royal Free Hospital), Alun D. Hughes(Aberystwyth University), Steven Law(The Royal Free Hospital), Yousuf Razvi(The Royal Free Hospital), Aldostefano Porcari(Azienda Sanitaria Universitaria Integrata di Trieste), Muhammad U. Rauf(The Royal Free Hospital), Tushar Kotecha(Royal Society), Francesco Bandera(University of Milan), Ana Martinez–Naharro(Children's Cancer and Leukaemia Group), Stefano Filisetti(IRCCS Policlinico San Donato), Paolo Massa(MACOM (United States)), G. Cabras(The Royal Free Hospital), Roos Eline Bolhuis(The Royal Free Hospital), Anita Jiang(The Royal Free Hospital), Daniel Knight(University College London)
European Heart Journal
May 22, 2023
Cited by 136


Related Papers